|Day's Range||10,447.01 - 10,622.35|
|52 Week Range||6,631.42 - 10,622.35|
Stock futures opened higher Sunday evening as investors mostly shrugged off a relentless climb in coronavirus cases in some regions in the US, and looked ahead to the start of corporate earnings season.
Market participants are bracing for the start of what will likely be the weakest corporate earnings season since the global financial crisis, as the coronavirus pandemic and measures to contain it hit business activity especially hard in the second quarter.
The coronavirus stock market rally is going great, with big-cap techs soaring. Here's what investors need to do now.
Coronavirus remains unchecked, but the Nasdaq is aiming for another all-time high. Is earnings season taking priority?
It’s no mystery why the Nasdaq Composite has soared, given the bright outlook for big technology companies. But tech is an increasingly crowded trade.
Our Roundtable experts identify stocks left behind in the rebound but poised to emerge even stronger after the crisis.
(PTON) stationary bike has quickly become an iconic product. The company’s chief financial officer is focused on a lower-priced treadmill. “We believe the running and bootcamp category is two-to-three [times] the size of the bike category,” Jill Woodworth said Wednesday on Barron’s Investing in Tech call.
A pre-IPO business development company has 19% of its assets invested in the secretive data-analytics company, not to mention a lot of other interesting assets. Plus: What does it mean when analysts are chasing the market on tech target prices?
Yahoo Finance's Rick Newman joined The Final Round to discuss the state of the US's economic recovery as coronavirus cases surge in parts of the country amid reopenings.
Here we highlight technology ETFs that have gained more than 25% year to date, defying the coronavirus-led hurdles in 2020.
Stocks rallied out of negative territory Friday after Gilead announced that remdesivir helped reduce COVID-19 mortality risk in a clinical trial.
The stock market has posted an amazing rebound from its March lows, but the real standout among major market benchmarks has been the Nasdaq Composite (NASDAQINDEX: ^IXIC). Tesla (NASDAQ: TSLA) and Zoom Video Communications (NASDAQ: ZM) have been among the top performers in the stock market lately, and today both companies saw their stocks move to new record levels. For Tesla, momentum seems to be unstoppable right now, even as short-sellers remain skeptical of the electric vehicle maker's prospects.
Stocks rose Friday, and the Nasdaq Composite hit yet another record high, after Gilead Sciences announced that its remdesivir treatment reduced the risk of death for Covid-19 patients, based on new data from the company.
Stocks rose Friday, with the Nasdaq Composite hit another record high. This comes after Gilead Sciences announced that its remdesivir treatment reduced the risk of death for COVID-19 patients, based on new data from the company. The Final Round panel breaks down the details.
The stalled nomination of Judy Shelton, President Donald Trump's controversial pick for the Federal Reserve, got a potential boost Friday when the Senate Banking Committee announced a July 21 vote on her nomination. Shelton's bid has languished since her confirmation hearing in February amid talk she didn't have enough committee support. Shelton, who was an informal Trump adviser during his presidential campaign, has been a long-time advocate for some form of tying the dollar's value to gold. She faces unanimous opposition from Democrats and some Republicans were on the fence. The committee will also vote on a second Trump Fed nominee, Christopher Waller, the director of research at the St. Louis Fed. Waller is expected to be confirmed easily.
U.S. stocks ended higher Friday, with support attributed in part to optimism over a coronavirus treatment as investors attempt to gauge the threat to the economic outlook from a rise in COVID-19 cases. The Dow Jones Industrial Average (DJIA) rose 369.21 points, or 1.4%, to close at 26,075.30. On Thursday, the Dow fell 361.19 points, or 1.4%, to end at 25,706.09; the S&P 500 index lost 17.89 points, or 0.6%, to end at 3,152.05; and the tech-heavy Nasdaq Composite Index closed up 55.25 points, or 0.5%, at 10,547.75, marking its third record in a row and its 27th of 2020.
The Nasdaq composite lagged Friday but continued to impress as it nearly hit a record high and closed near session highs.
Stocks ended higher in thin trade Friday, getting a lift from positive news on a coronavirus treatment. The Dow Jones Industrial Average rose around 369 points, or 1.4%, to end near 26,075, according to preliminary figures, while the S&P 500 advanced around 33 points, or 1%, to end near 3,185. The tech heavy Nasdaq Composite rose nearly 70 points, or 0.7%, to end near 10,617, marking its third consecutive record close. Stocks shed premarket weakness after drug maker Gilead Sciences Inc. released potentially promising data about remdesivir that indicates the experimental COVID-19 drug may reduce deaths.
Kathy Entwistle, Managing Director at Morgan Stanley, joins Yahoo Finance’s Kristin Myers to discuss expectations from the upcoming earnings season, along with U.S.-China trade tensions.
The Nasdaq is like "a train that is moving faster than any train we've ever seen before,” says one veteran strategist.
Dr. Alison Haddock,Emergency Medicine Physician and Assistant Professor of Emergency Medicine at Baylor University, joins Yahoo Finance’s Zack Guzman to break down the latest coronavirus developments as U.S. cases surpass 3 million.
The Dow Jones outperformed in afternoon trading Friday, led by Goldman Sachs and JPMorgan. A slew of financial stocks kick off earnings season next week.
In a Yahoo Finance Premium webinar, Brian Shannon, CMT discusses why trading legends missed the bulk of the post-Covid stock market rally and explains how traders can avoid common pitfalls, such as impulsive trading, by having a trading plan and knowing their time frame.